title: Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.
abstract: Hepatocellular carcinomas exhibit heterogeneous morphologies by routine light microscopy. Although some morphologies represent insignificant variations in growth patterns, others may represent unrecognized subtypes of hepatocellular carcinoma. Identification of these subtypes could lead to separation of hepatocellular carcinomas into discrete groups with unique underlying genetic changes, prognosis, or therapeutic responses. In order to identify potential subtypes, two pathologists independently screened a cohort of 219 unselected hepatocellular carcinoma resection specimens and divided cases into potential subtypes. One of these promising candidate subtypes was further evaluated using histological and molecular techniques. This subtype was characterized by a unique and consistent set of histological features: smooth chromophobic cytoplasm, abrupt focal nuclear anaplasia (small clusters of tumor cells with marked nuclear anaplasia in a background of tumor cells with bland nuclear cytology), and scattered microscopic pseudocysts--we designate this variant as 'chromophobe hepatocellular carcinoma with abrupt anaplasia'. Thirteen cases were identified (6% of all hepatocellular carcinomas), including 6 men and 7 women with an average age of 61 years. Six cases occurred in cirrhotic livers. Serum AFP was elevated in 6 out of 10 cases. There were a variety of underlying liver diseases, but cases were enrichment for chronic hepatitis B, P=0.006. Interestingly, at the molecular level, this variant was strongly associated with the alternative lengthening of telomere (ALT) phenotype by telomere FISH. ALT is a telomerase-independent mechanism of telomere maintenance and is found in approximately 8% of unselected hepatocellular carcinomas. In contrast, 11/12 (92%) of the cases of chromophobe hepatocellular carcinoma with abrupt anaplasia were ALT-positive. In summary, we propose that chromophobe hepatocellular carcinoma with abrupt anaplasia represents a new subtype of hepatocellular carcinoma with unique morphological and molecular features.
authors: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors: Laura D
authors: LD
authors: Wood
authors: Christopher M
authors: CM
authors: Heaphy
authors: Hubert Darius-J
authors: HD
authors: Daniel
authors: Bita V
authors: BV
authors: Naini
authors: Charles R
authors: CR
authors: Lassman
authors: May R
authors: MR
authors: Arroyo
authors: Ihab R
authors: IR
authors: Kamel
authors: David P
authors: DP
authors: Cosgrove
authors: John K
authors: JK
authors: Boitnott
authors: Alan K
authors: AK
authors: Meeker
authors: Michael S
authors: MS
authors: Torbenson
mesh_terms: D000708:Anaplasia / Q000473:pathology; D006528:Carcinoma, Hepatocellular / Q000145:classification* / Q000235:genetics / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008113:Liver Neoplasms / Q000145:classification* / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D016615:Telomere
references: J Hepatol. 2011 Aug;55(2):276-7
references: 21439335
references: Lancet. 2012 Mar 31;379(9822):1245-55
references: 22353262
references: Mod Pathol. 2011 Mar;24(3):390-5
references: 21113139
references: Nat Rev Genet. 2010 May;11(5):319-30
references: 20351727
references: Am J Pathol. 2011 Oct;179(4):1608-15
references: 21888887
references: Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14075-80
references: 20651253
references: FEBS Lett. 2010 Sep 10;584(17):3800-11
references: 20542034
references: Adv Anat Pathol. 2007 May;14(3):217-23
references: 17452818
references: Oncologist. 2010;15 Suppl 4:5-13
references: 21115576
references: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10635-40
references: 12953102
references: Cancer Res. 2006 Jul 1;66(13):6473-6
references: 16818615
references: Nat Genet. 2012 May 27;44(7):765-9
references: 22634754
references: Science. 2011 Jul 22;333(6041):425
references: 21719641
references: Int J Clin Oncol. 2010 Jun;15(3):242-55
references: 20509038
references: Nature. 2012 Jan 29;482(7384):226-31
references: 22286061